Results 171 to 180 of about 180,947 (337)

Additional file 1: Table S1. of Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohnâ s disease patients in a mouse model of colitis

open access: yes, 2015
Presenting sample demographics. Summary of the main features of CD patients from which adCD-MSCs were isolated. Data for healthy donors from which adHD-MSCs were isolated for the comparison of biological properties are also shown. (DOC 34 kb)
Forte, Dorian   +14 more
openaire   +1 more source

Motion Mitigation Techniques for Abdominal and Cardiac MR Imaging

open access: yesJournal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT MRI of the heart and abdominal organs provides unparalleled soft tissue contrast and quantitative biomarkers, yet remains highly susceptible to physiological motion. Contractions of the myocardium, respiratory excursions, peristalsis, vascular pulsatility, and unpredictable bulk patient movement generate artifacts that impair image quality ...
Eric M. Schrauben   +3 more
wiley   +1 more source

Additional file 2: of Prognostic biomarkers to identify patients destined to develop severe Crohnâ s disease who may benefit from early biological therapy: protocol for a systematic review, meta-analysis and external validation

open access: yes, 2016
PRISMA-P 2015 Checklist. (DOCX 31 kb)
Halligan, Steve   +7 more
openaire   +1 more source

Oral rehydration solution for the management of fluid and electrolyte disturbances in patients with an ileostomy: A scoping review

open access: yesJournal of Parenteral and Enteral Nutrition, EarlyView.
Abstract Ileostomy creation is common among patients with colorectal cancer, diverticulitis, and inflammatory bowel disease. Surgical removal or diversion of the colon can result in nutrition complications, most notably dehydration—a leading cause of hospital readmission—and increased risk of kidney injury.
Austin J. Hoeg   +9 more
wiley   +1 more source

Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results [PDF]

open access: yes, 2017
Background: Biological agents, such as infliximab, have transformed the outcomes of patients with immune-mediated inflammatory diseases. The advent of biosimilar treatment options such as CT-P13 promises to improve the availability of biological therapy,
Argüelles Arias, Federico   +7 more
core  

Additional file 1: of Prognostic biomarkers to identify patients destined to develop severe Crohnâ s disease who may benefit from early biological therapy: protocol for a systematic review, meta-analysis and external validation

open access: yes, 2016
Crohnâ s systematic review definitions and analysis. (DOC 99 kb)
Halligan, Steve   +7 more
openaire   +1 more source

Effect of smoking over one pack daily on implant healing and health: A cohort study

open access: yesJournal of Periodontology, EarlyView.
Abstract Background This prospective cohort trial examines the effects of heavy smoking on peri‐implant marginal bone loss (MBL) and implant survival rates over 15 months. Methods Thirty subjects, categorized as either smokers (more than 20 cigarettes daily for over 5 years) or non‐smokers, were initially recruited with pocket depths ≤ 5 mm and at ...
Yaniv Mayer   +9 more
wiley   +1 more source

Additional file 2: Table S2. of Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohnâ s disease patients in a mouse model of colitis

open access: yes, 2015
Presenting DAI score criteria. Summary of the criteria used to assign the scores added to determine the DAI in mice daily. (DOCX 13 kb)
Forte, Dorian   +14 more
openaire   +1 more source

Reshaping study design for faster extrapolation‐based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN–NASPGHAN position paper

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Children with inflammatory bowel diseases (IBD) have limited access to the available advanced therapies, given the lengthy gap between adult and pediatric approval. We aimed to review key hurdles for pediatric trials and recommend practical solutions.
Dan Turner   +21 more
wiley   +1 more source

Reprograming of gut microbiome energy metabolism by the FUT2 Crohn’s disease risk polymorphism [PDF]

open access: hybrid, 2014
Maomeng Tong   +14 more
openalex   +1 more source

Home - About - Disclaimer - Privacy